The RetinaRisk API enables access to our clinically validated algorithm for hospitals, clinics, diabetes platforms, pharmaceuticals and health insurers in order to streamline eye screening, identify high-risk patients and provide more personalized care.
The API easily connects to your IT systems to facilitate risk stratification of diabetic patients, based on required risk factors. High-risk patients will be called in first for eye screening, enhancing the clinical safety of those patients, while low-risk patients may come less frequently, without compromising their clinical safety.
The RetinaRisk API is easy to integrate and we offer support for every client.
The RetinaRisk API returns your calculation results in seconds from anywhere in the world.
With 99.95% uptime, the RetinaRisk API is among the most reliable in the business.
The RetinaRisk algorithm was developed by Dr. Einar Stefansson, Professor at the Department of Ophthalmology, University of Iceland and Dr. Arna Gudmundsdottir, Endocrinologist at the National Hospital Reykjavik, who have decades of experience in screening for diabetic retinopathy and treating diabetes. Our algorithm is based on extensive international research and has been clinically validated in over 25.000 diabetic patients in three continents and found to be robust.